Rausch S - Search Results

1

Simultaneous Extraction of RNA and Metabolites from Single Kidney Tissue Specimens for Combined Transcriptomic and Metabolomic Profiling.

Leuthold P, Schwab M, Hofmann U, Winter S, Rausch S, Pollak MN, Hennenlotter J, Bedke J, Schaeffeler E, Haag M. Leuthold P, et al. Among authors: rausch s. J Proteome Res. 2018 Sep 7;17(9):3039-3049. doi: 10.1021/acs.jproteome.8b00199. Epub 2018 Aug 23. J Proteome Res. 2018. PMID: 30091608

2

IMA901 for metastatic renal cell carcinoma in the context of new approaches to immunotherapy.

Rausch S, Kruck S, Stenzl A, Bedke J. Rausch S, et al. Future Oncol. 2014 May;10(6):937-48. doi: 10.2217/fon.14.61. Future Oncol. 2014. PMID: 24941980 Review.

3

Impaired estimated glomerular filtration rate is a significant predictor for non-muscle-invasive bladder cancer recurrence and progression--introducing a novel prognostic model for bladder cancer recurrence.

Rausch S, Hennenlotter J, Todenhöfer T, Aufderklamm S, Schwentner C, Sievert KD, Stenzl A, Gakis G. Rausch S, et al. Urol Oncol. 2014 Nov;32(8):1178-83. doi: 10.1016/j.urolonc.2014.05.009. Epub 2014 Jun 21. Urol Oncol. 2014. PMID: 24962661

4

[Elective organ and function preservation in ureter and renal pelvis tumors].

Rausch S, Gakis G, Bedke J, Stenzl A. Rausch S, et al. Urologe A. 2014 Sep;53(9):1284-94. doi: 10.1007/s00120-014-3557-6. Urologe A. 2014. PMID: 25148912 German.

5

mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer.

Rausch S, Schwentner C, Stenzl A, Bedke J. Rausch S, et al. Hum Vaccin Immunother. 2014;10(11):3146-52. doi: 10.4161/hv.29553. Hum Vaccin Immunother. 2014. PMID: 25483661 Free PMC article. Review.

6

Analysis of early morbidity and functional outcome of thulium: yttrium-aluminum-garnet laser enucleation for benign prostate enlargement: patient age and prostate size determine adverse surgical outcome.

Rausch S, Heider T, Bedke J, Kruck S, Schwentner C, Fischer K, Stenzl A, Kälble T. Rausch S, et al. Urology. 2015 Jan;85(1):182-8. doi: 10.1016/j.urology.2014.10.002. Urology. 2015. PMID: 25530383

7

Stepwise application of urine markers to detect tumor recurrence in patients undergoing surveillance for non-muscle-invasive bladder cancer.

Todenhöfer T, Hennenlotter J, Esser M, Mohrhardt S, Aufderklamm S, Böttge J, Rausch S, Mischinger J, Bier S, Gakis G, Kuehs U, Stenzl A, Schwentner C. Todenhöfer T, et al. Among authors: rausch s. Dis Markers. 2014;2014:973406. doi: 10.1155/2014/973406. Epub 2014 Dec 22. Dis Markers. 2014. PMID: 25587206 Free PMC article.

8

Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron.

Büttner F, Winter S, Rausch S, Reustle A, Kruck S, Junker K, Stenzl A, Agaimy A, Hartmann A, Bedke J, Schwab M, Schaeffeler E. Büttner F, et al. Among authors: rausch s. Eur Urol. 2015 Dec;68(6):1016-20. doi: 10.1016/j.eururo.2015.05.045. Epub 2015 Jun 12. Eur Urol. 2015. PMID: 26072688

9

MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma.

Fisel P, Stühler V, Bedke J, Winter S, Rausch S, Hennenlotter J, Nies AT, Stenzl A, Scharpf M, Fend F, Kruck S, Schwab M, Schaeffeler E. Fisel P, et al. Among authors: rausch s. Oncotarget. 2015 Oct 13;6(31):30615-27. doi: 10.18632/oncotarget.5593. Oncotarget. 2015. PMID: 26384346 Free PMC article.

10

[Leiomyomatous renal cell carcinoma : Controversy around a new entity].

Rausch S, Scharpf M, Moch H, Stenzl A, Bedke J. Rausch S, et al. Urologe A. 2016 Mar;55(3):376-80. doi: 10.1007/s00120-015-3975-0. Urologe A. 2016. PMID: 26556266 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

312 results

Search Page

Filters